-
State Street SPDR S&P Pharmaceuticals ETF (XPH $57.27)
- $57.27 P/E (TTM): 17.0X Cap: $297M
- View XPH Profile
- View Questions on XPH
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $72.06)
- $72.06 P/E (TTM): 26.69X Cap: $574M
- View XHC Profile
- View Questions on XHC
-
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
-
iShares U.S. Pharmaceuticals ETF (IHE $90.36)
- $90.36 P/E (TTM): 21.49X Cap: $1.01B
- View IHE Profile
- View Questions on IHE
-
State Street SPDR S&P Pharmaceuticals ETF (XPH $57.27)
- $57.27 P/E (TTM): 17.0X Cap: $297M
- View XPH Profile
- View Questions on XPH
Q: Is there a good ETF that covers the US large pharmaceuticals, either hedged or not? And if so which way is better right now?
Insiders
Share Information
SEC Filings
News and Media